Literature DB >> 26710908

[Application research of percutaneous patent ductus arteriosus closure by femoral vein approach under echocardiography guidance].

Shouzheng Wang1, Yao Liu1, Shan Wang1, Wenbin Ouyang1, Shengshou Hu1, Shoujun Li1, Dawei Zhang1, Fengwen Zhang1, Kunjing Pang1, Nengxin Fang1, Xiangbin Pan2.   

Abstract

OBJECTIVE: To avoid the injuries of radiation and contrast agent, we assess the efficacy and safety of percutaneous patent ductus arteriosus (PDA) closure by femoral vein approach solely under echocardiography guidance.
METHODS: From January 2014 to December 2014, 25 patients in Fuwai hospital with PDA were selected, with mean age (4.5 ± 2.1) years and mean body weight (19 ± 7) kg. The mean diameter of PDA was (5.9 ± 1.2) mm. Patients were all treated by percutaneous PDA closure solely by echocardiography guidance in femoral vein. The effect of the procedure was evaluated by echocardiography. Follow-up was given at one month after procedure.
RESULTS: Twenty-three cases were successfully treated with percutaneous PDA closure by femoral vein approach solely under echocardiography guidance, while two patients was closed by femoral artery approach because guide wires could not pass through PDA. The procedural time was (33 ± 5) min. The mean diameter of PDA occluder was (11.4 ± 1.5) mm. Postoperative early trivial residual shunt occurred in three patients. All patients survived with no peripheral vascular injury or complications such as cardiac perforation. Hospitalization time was (3.6 ± 0.8) days. At one month follow-up, no complications such as residual shunt or pericardial effusion were occurred.
CONCLUSION: Echocardiography guided percutaneous PDA closure by femoral vein approach is safe and effective, and avoids the use of radiation and contrast agents.

Entities:  

Mesh:

Year:  2015        PMID: 26710908

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  1 in total

1.  New Nano-Film Single-Rivet Patent Ductus Arteriosus Occluders: A Prospective, Randomized and Double-blind Study.

Authors:  Xiao-Ke Shang; Mei Liu; Hong-Jun Li; Rong Lu; Shan-Shan Ding; Bin Wang; Nian-Guo Dong; Shu Chen
Journal:  Curr Med Sci       Date:  2018-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.